Current Edition

Proactive Safety Management for Established Healthcare Products

A recent analysis shows that more than $290 billion of prescription drug sales are at risk from patent expirations between 2011 and 2018. Chitra Lele at Sciformix discusses why patent expirations is on the rise and organizations focusing on market expansion opportunities, substantial penetration of generic medicinal products in both developed as well as emerging markets, is now a clear trend in the industry.